Traditional marketing channels narrow
This summer, Chinese authorities issued stricter rules for drug company staff who provide product information to doctors and hospitals, part of a multi-year drive to root out bribery in healthcare. Zhejiang Xianju Pharmaceutical said the rules hit sales, while a sales director at Xian Shijishengkang Pharmaceutical cited hospital visit restrictions as a particular obstacle.
A wave of AI apps for doctors
Several new platforms are emerging and attracting drugmakers’ interest:
- Alibaba Health has developed the Hydrion app and is considering a model allowing promoted research and clinical evidence to appear alongside AI-generated answers.
- Medical education firm PICA Health has integrated JD Health’s Zhiyi AI assistant, aiming to offer drugmakers academic promotion and physician education services.
- Drugmakers have held talks with Yidu Tech about marketing on its Yidu Evidence app, though such functionality is not yet offered.
- Frost & Sullivan estimates digital health marketing spending in China will grow at a compound annual rate of 27.5% from 2027 to 2030, reaching 274.4 billion yuan.

















